IDEXX LABORATORIES, INC. (NASDAQ:IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

IDEXX LABORATORIES, INC. (NASDAQ:IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02 of the Original Report in its entirety solely to
correct a scriveners error. No other changes were made to the
Original Report.

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers;Compensatory
Arrangements of Certain Officers.

On February 14, 2017, Mr. Thomas Craig, a Class II Director,
provided IDEXX Laboratories, Inc. (the Company) notice of his
intention to retire from the Board of Directors (the Board)
immediately following the expiration of his term on the date of
the Companys 2017 annual meeting of stockholders to be held on
May 3, 2017 (the 2017 Annual Meeting). Mr.Craigs decision to
retire from the Board does not arise from any disagreement with
the Company on any matter relating to the Companys operations,
policies or practices.

In addition, and in accordance with the Company’s Corporate
Governance Guidelines, Dr. Barry C. Johnson, a Class III
Director, having reached the mandatory retirement age of 73, will
also retire effective on the date of the 2017 Annual Meeting.

The Company thanks each of Mr. Craig and Dr. Johnson for his
service and commitment during his tenure as a member of the
Board.

In accordance with the Companys bylaws, the Board reduced the
size of the Board to eight members, the size of Class II to
three, and the size of Class III to two, effective upon Mr.
Craigs and Dr. Johnsons retirements from the Board.


About IDEXX LABORATORIES, INC. (NASDAQ:IDXX)

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company’s segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

IDEXX LABORATORIES, INC. (NASDAQ:IDXX) Recent Trading Information

IDEXX LABORATORIES, INC. (NASDAQ:IDXX) closed its last trading session down -0.15 at 142.25 with 584,463 shares trading hands.